Daxor Ev To Sales from 2010 to 2025

DXR Stock  USD 8.50  0.41  5.07%   
Daxor EV To Sales yearly trend continues to be relatively stable with very little volatility. EV To Sales is likely to grow to 334.09 this year. EV To Sales is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. View All Fundamentals
 
EV To Sales  
First Reported
2010-12-31
Previous Quarter
318.18
Current Value
334.09
Quarterly Volatility
158.81396246
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Daxor financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Daxor's main balance sheet or income statement drivers, such as Depreciation And Amortization of 612 K, Interest Expense of 66.3 K or Selling General Administrative of 335.8 K, as well as many indicators such as Price To Sales Ratio of 329, Dividend Yield of 0.0074 or PTB Ratio of 1.33. Daxor financial statements analysis is a perfect complement when working with Daxor Valuation or Volatility modules.
  
Check out the analysis of Daxor Correlation against competitors.
To learn how to invest in Daxor Stock, please use our How to Invest in Daxor guide.

Latest Daxor's Ev To Sales Growth Pattern

Below is the plot of the Ev To Sales of Daxor over the last few years. It is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. Daxor's EV To Sales historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Daxor's overall financial position and show how it may be relating to other accounts over time.
Ev To Sales10 Years Trend
Slightly volatile
   Ev To Sales   
       Timeline  

Daxor Ev To Sales Regression Statistics

Arithmetic Mean34.44
Geometric Mean29.46
Coefficient Of Variation461.15
Mean Deviation104.03
Median6.12
Standard Deviation158.81
Sample Variance25,222
Range652
R-Value0.47
Mean Square Error21,042
R-Squared0.22
Significance0.07
Slope15.69
Total Sum of Squares378,328

Daxor Ev To Sales History

2025 334.09
2024 318.18
2023 276.68
2022 6.12
2021 8.22
2020 -48.93
2019 -317.96

About Daxor Financial Statements

Daxor shareholders use historical fundamental indicators, such as Ev To Sales, to determine how well the company is positioned to perform in the future. Although Daxor investors may analyze each financial statement separately, they are all interrelated. The changes in Daxor's assets and liabilities, for example, are also reflected in the revenues and expenses on on Daxor's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EV To Sales 318.18  334.09 

Pair Trading with Daxor

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daxor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daxor will appreciate offsetting losses from the drop in the long position's value.

Moving together with Daxor Stock

  0.81CI Cigna CorpPairCorr

Moving against Daxor Stock

  0.72ECOR Electrocore LLCPairCorr
  0.64VVOS Vivos TherapeuticsPairCorr
  0.6EW Edwards Lifesciences Corp Sell-off TrendPairCorr
  0.52EMBC Embecta CorpPairCorr
  0.46OM Outset MedicalPairCorr
The ability to find closely correlated positions to Daxor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daxor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daxor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daxor to buy it.
The correlation of Daxor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daxor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daxor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daxor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Daxor Stock Analysis

When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.